drug

HRS-3738

updated 3mo ago

by Jiangsu Hengrui Pharmaceuticals Co Ltd

community read0 votes

🐶 often sniffed alongside

top 4

all catalysts(1)

phase 2 initiation · 1

Apr 27, 2026

phase 2 initiation

4mo ago

Jiangsu Hengrui Pharmaceuticals Co Ltd — HRS-3738 (Phase II Trial Initiation)

HRS-3738

→

Trials studying HRS-3738

phase1Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myelomaactive not recruitingn=74

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

HRS-3738

updated 3mo ago

by Jiangsu Hengrui Pharmaceuticals Co Ltd

community read0 votes

🐶 often sniffed alongside

top 4

all catalysts(1)

phase 2 initiation · 1

Apr 27, 2026

phase 2 initiation

4mo ago

Jiangsu Hengrui Pharmaceuticals Co Ltd — HRS-3738 (Phase II Trial Initiation)

HRS-3738

→

Trials studying HRS-3738

phase1Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myelomaactive not recruitingn=74

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

HRS-3738

🐶 often sniffed alongside

all catalysts(1)

Trials studying HRS-3738

News(0)

Report a data issue

comments(0)

HRS-3738

🐶 often sniffed alongside

all catalysts(1)

Trials studying HRS-3738

News(0)

Report a data issue

comments(0)